Helen M. Thackray

BCRX

Helen M. Thackray serves as Chief R&D Officer at BioCryst Pharmaceuticals, Inc. (BCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$175.8K

Total Sells

9 trades

$462.0K

Net Position

Net Seller

$286.2K

Companies Traded

BCRX

Active Period

Apr 2022 – Mar 2025

10 total trades

Most Recent

Sell BCRX

Mar 31, 2025 · $56.4K

Helen M. Thackray's Insider Trading at BioCryst Pharmaceuticals, Inc. (BCRX)

Buys

1 · $175.8K

Sells

9 · $462.0K

Total Shares Bought

30,000

Total Shares Sold

54,632

BCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 31, 2025	Sell	7,525	$7.50	$56.4K
Dec 19, 2024	Sell	6,096	$7.39	$45.0K
Dec 14, 2024	Sell	7,150	$7.53	$53.8K
May 14, 2024	Buy	30,000	$5.86	$175.8K
Mar 31, 2024	Sell	7,525	$5.08	$38.2K
Dec 19, 2023	Sell	5,580	$6.05	$33.8K
Dec 14, 2023	Sell	3,031	$6.43	$19.5K
Apr 3, 2023	Sell	7,000	$8.29	$58.0K
Dec 15, 2022	Sell	3,125	$10.89	$34.0K
Apr 1, 2022	Sell	7,600	$16.20	$123.1K